Herbalife Ltd. (HLF) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$13.05 +0.93% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.05

Herbalife Ltd. (HLF) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C β€’ HOLD / WATCH Cap $1.36B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HLF Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is HLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Herbalife Ltd. (NYSE: HLF) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $13.05 (+0.93% 1D, market cap $1.36B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, HLF ranks #140 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does HLF compare to NUS and ZSTK in the Health Care sector?
β–Ό

Within the Health Care sector (Other Pharmaceuticals), HLF carries a Roarable C (64/100 RQD), trailing P/E of 5.9x, gross margin of 77.9%, and ROIC of 34.4%. By comparison, NUS (Nu Skin Enterprises Inc.) holds a D+ grade (53/100 RQD, P/E N/A, ROIC 6.7%, cap $228.3M) and ZSTK (ZeroStack Corp.) posts a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while HLF leads on capital efficiency (34.4% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HLF?
β–Ό

Per HLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001180262), Herbalife Ltd. generated $5.04B in revenue (+0.9% YoY), $228.3M in net income, and $252.9M in free cash flow against $2.79B in total assets and $1.97B in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)β€”profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.05 (-0.02%)🧬 Cannibal Buyback (-2.64% YoY Shares)βš™οΈ Cash Engine: 18/20 (A) β€’ 5% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY β€’ 55.2% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERHOLD / WATCH β€’ C
025507510064
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B Β· Rk D+
Cash (18)Whales (8)SEC (12)Macro (9)CEO (17)
Each axis scored 0–20
12M PRICE TARGET CONE+2.7% Base Target
$21 Bull$13 Base$10 Bear
πŸ“¬ FREE HLF RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for HLF)Realized 20D OHLCV Swing Band: Β±8%
Deterministic 5-Pillar Attribution (64/100 Composite)
πŸ” WHY HLF SCORES 64/100 (C) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+18/20 pts (28% of score)

SEC XBRL FY 2025 (10-K): 5% FCF Margin ($252.9M FCF) & 77.9% Gross Margin

β–² #2 Bullish Driver: Insider Conviction & Share Dilution+17/20 pts (27% of score)

SEC Form 4 / 13F Thermometer: 85% Net Buy β€’ Cannibal Buyback (-2.64% YoY Shares)

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
72
Grade B$13.61+2% Next Q
Q2 (-2Q)
69
Grade B-$13.88-4.3% Next Q
Q3 (-1Q)
67
Grade B-$13.28-1.7% Next Q
Current
64
Grade C$13.05+1.1% Hist 90D Ξ±
Trajectory: B (72) β†’ C (64)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the HLF Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 64/100 (C) score, HLF faces multiple-compression risk if 5.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.72) or 200D SMA ($13.99) invalidates the momentum regime and cuts Target Base ($13.40) toward Bear Floor ($10.45).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HLFβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œHLF Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How HLF Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$252.9M (5% FCF Margin)
Revenue$5.04BGross Profit $3.92B (77.9%)Cost of Sales $1.11BOp Profit $481.0M (9.5%)OpEx (R&D/SG&A) $3.44BNet Profit$228.3M (4.5%)Tax/Other $252.7M

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $5.06B
FY24
Rev $4.99B
FY25
Rev $5.04B
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$5.04B77.9%9.5%$228.3M$252.9M34.4%
FY 2024$4.99B77.9%7.7%$254.3M$163.4M40.1%
FY 2023$5.06B77.9%7%$142.2M$357.5M34.4%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HLF)

  • βœ“Walkthrough of HLF's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HLF // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -17.51%πŸ“ HORIZONTAL RANGE
2026-11-02O $13.38H $13.38L $12.93C $13.05VOL 1.65M
RES: $15.29SUP: $9.85SMA50: $12.72SMA200: $13.99
$17.27$15.41$13.55$11.69$9.83RES $15.29SUP $9.85$13.052026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HLF Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
-11.1%/yr Implied 5Y Growth

vs. +0.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HLF today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for HLF. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HLF today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HLF)

Health Care Rank #140 of 1016 βš”οΈ NUS vs HLF Full Matrix β†’

1. Head-to-Head Health Care Peer Comparison (HLF vs. NUS, ZSTK, ESYN, CAH)

Industry: Other Pharmaceuticals (10 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Herbalife Ltd. (HLF) ranks #140 by composite RQD confidence (64/100, grade C) and #320 by equity capitalization ($1.36B). Within this direct 5-issuer industry benchmark cohort, HLF leads on earnings valuation at 5.9x trailing P/E, while HLF leads on capital efficiency and profitability with 34.4% ROIC and 77.9% gross margin. CAH currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with HLF at 64/100 (C).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HLF ACTIVE
Herbalife Ltd.
C 64/100 5.9x 77.9% 34.4% +0.93% $1.36B Benchmark Subject
NUS
Nu Skin Enterprises Inc.
D+ 53/100 β€” 69.4% 6.7% -0.85% $228.3M /nus-vs-hlf β†’
ZSTK
ZeroStack Corp.
E 25/100 β€” 4.6% -35.0% -5.12% $63.9M /zstk-vs-hlf β†’
ESYN
EnerSyn Global Inc.
D- 40/100 β€” 53.0% -35.0% -4.37% $54.4M /esyn-vs-hlf β†’
CAH
Cardinal Health Inc.
B 73/100 37.2x 3.7% 29.7% -0.24% $58.14B /cah-vs-hlf β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001180262

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Herbalife Ltd. (HLF) reported GAAP revenue of $5.04B (+0.9% vs. FY2024 revenue of $4.99B , and -0.5% cumulative change since FY2023) , GAAP net income of $228.3M, operating cash flow of $333.3M, and free cash flow of $252.9M (+54.8% YoY). On the balance sheet, HLF closed FY2025 with $2.79B in total assets against $1.97B in total debt (Altman Z-Score: 2.39, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $5.04B $228.3M $333.3M $252.9M $2.79B $1.97B
FY2024 (FY) 2024-12-31 $4.99B $254.3M $285.4M $163.4M $2.73B $1.98B
FY2023 (FY) 2023-12-31 $5.06B $142.2M $357.5M $357.5M β€” β€”

3. HLF Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Herbalife Ltd. (NYSE: HLF) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $13.05 (+0.93% 1D, market cap $1.36B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, HLF ranks #140 in composite RQD confidence.

How does HLF compare to NUS and ZSTK in the Health Care sector?

Within the Health Care sector (Other Pharmaceuticals), HLF carries a Roarable C (64/100 RQD), trailing P/E of 5.9x, gross margin of 77.9%, and ROIC of 34.4%. By comparison, NUS (Nu Skin Enterprises Inc.) holds a D+ grade (53/100 RQD, P/E N/A, ROIC 6.7%, cap $228.3M) and ZSTK (ZeroStack Corp.) posts a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while HLF leads on capital efficiency (34.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HLF?

Per HLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001180262), Herbalife Ltd. generated $5.04B in revenue (+0.9% YoY), $228.3M in net income, and $252.9M in free cash flow against $2.79B in total assets and $1.97B in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)β€”profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HLF trading relative to its 50-day, 200-day, and 52-week technical levels?

HLF last traded at $13.05 (+0.93% on volume of 1,520,210 shares), positioning the stock +2.59% above its 50-day simple moving average ($12.72) and -6.72% below its 200-day simple moving average ($13.99). Across its 52-week range of $7.56 to $20.40, HLF sits at the 42.8% percentile with a 14-day RSI of 45.7 (NEUTRAL RANGE) and an implied next-earnings move of Β±8.0% ($12.01 to $14.09).

HLF Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

How profitable is Herbalife Ltd. (HLF)?

In FY 2025 (10-K), HLF converted $5.0B of revenue into a 77.9% gross margin, 9.5% operating margin, and $252.9M in free cash flow (5% FCF margin).

ROARABLE RATING BRIEF β€’ RQD 64/100 (C) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

HLF β€” Herbalife Ltd.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:29:29Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, HLF scores 64 out of 100, earning a letter grade of C and the verdict "Roarable Hold β€” Fair / Balanced Risk-Reward." The five pillars are: Fundamental Cash Engine at 18 of 20 (ROIC 34.4%; FCF yield 18.66%), the strongest contributor and the main source of the score; Whale 13F Flow at 8 of 20 (institutional accumulation and options positioning), a weak contributor; Insider Conviction at 17 of 20 (SEC Form 4 and Congressional PTR cluster flow), a strong contributor; Macro Regime Fit at 9 of 20 (beta 1.0; sector sensitivity), a middling contributor; and Forensic Balance Sheet at 12 of 20 (Altman Z 2.39; Piotroski F 6/9; Debt/Equity 0.5), a moderate contributor.

For a prospective investor evaluating the stock today, the pillar mix suggests the cash-generation case is the principal argument in favor, supported by insider-flow signals. The lower whale-flow and macro-fit scores indicate less institutional confirmation and a beta of 1.0 that tracks the broader market and sector. Valuation tradeoffs are visible in the market data: a trailing P/E of 5.9 and EV/EBITDA of 5.4 sit alongside an FCF yield of 18.66%, while the stock trades near the lower portion of its 52-week range. The balance sheet is rated as moderate rather than weak, but the Altman and Piotroski readings and reported debt of $1971.7M warrant attention in weighing downside scenarios. This is an analytical summary, not personalized advice.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
12.93$1.36B5.95.55.42.180%1.0$7.56 - $20.434.4%

Business

Herbalife Ltd. (HLF) is a NYSE-listed issuer in the Health Care sector and Other Pharmaceuticals industry, per the Profile. Per the Market Data, the company reports a gross margin of 77.9%, an operating margin of 9.5%, and a net margin of 4.5%. Not available in source data for product lines, customer segments, or specific revenue-generation mechanics.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$5037.5M$481.0M$228.3MN/A$252.9M$353.1M$1971.7M
FY 2024$4993.1M$385.9M$254.3MN/A$163.4M$415.3M$1976.6M
FY 2023$5062.4M$356.4M$142.2MN/A$357.5MN/AN/A

Per the SEC financials, revenue was broadly flat across the three reported periods, while operating income rose from $356.4M (FY 2023) to $481.0M (FY 2025). Net income moved from $142.2M to $254.3M and then to $228.3M. Per the Roarable RQD rating, ROIC is 34.4%, and the forensic inputs are an Altman Z-Score of 2.39, a Piotroski F-Score of 6/9, and a Debt/Equity ratio of 0.5. Cash declined from $415.3M to $353.1M over the two most recent periods, while debt was broadly stable at $1976.6M and $1971.7M.

Recent Catalysts & News Wire Analysis

Per the recent news data, the feed contains six items dated within roughly the past 15 hours, tagged by impact label:

  • Market Wire (YELLOW): Yahoo! Finance Canada and Yahoo Finance coverage of general market action and fair-value commentary.
  • Catalyst (GREEN): GuruFocus reported a share move of 4.5% alongside a GF Score of 62; MarketBeat reported a 5% share move.
  • Risk Watch (RED): Benzinga listed HLF among "Top 3 Risk Off Stocks" for Q4.
  • Catalyst (GREEN): Simply Wall St coverage addressed investor reaction to slowing sales growth.

Per the Butterfly Supply-Chain Graph, no proprietary signals or butterfly links are recorded. The headlines are summary-level and do not include underlying figures beyond those noted.

Open Questions

  • What drives the reported revenue plateau across FY 2023–FY 2025, and what is the company's stated growth trajectory?
  • What explains the decline in cash from $415.3M to $353.1M despite positive reported FCF in FY 2025?
  • What are the terms, maturities, and interest costs on the $1971.7M of reported debt?
  • What is the underlying basis for the 4.5% and 5% share moves referenced in the news wire, and do they reflect company-specific events?
  • Why is EPS reported as N/A for every period despite positive net income?

HLF Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Herbalife Ltd. (HLF) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to HLF Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HLF Bull vs. Bear Conversation Board β€” What's Your Call at $13.05?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HLF 🐻 50% BEARISH CONVICTION
1. Pick Your Side on HLF:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $13.96 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is HLF (C β€’ RQD 64/100) a Buy at $12.93?

Welcome to the HLF (Herbalife Ltd.) Roar Pit. Current RQD Composite is 64/100 (Roarable Hold β€” Fair / Balanced Risk-Reward) in Other Pharmaceuticals. Bulls point to capital efficiency (34.4% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $10.21 (-21.0%)
Spot @ $12.93

Pump the brakes on HLF β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on HLF, but look at what you are paying: 5.9x trailing P/E with 77.9% gross margins. Unless Herbalife Ltd. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $16.03 (+24.0%)
Spot @ $12.93

HLF cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on HLF, the market is fixating on short-term headline noise in Other Pharmaceuticals and ignoring the balance sheet and cash flow trajectory. At $12.93 (52-wk range $7.56 - $20.40), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%